Aim: The aim of this study was to evaluate the effectiveness and safety of a transvaginal approach for chorionic villous sampling (CVS).
Methods: We carried out a retrospective data analysis of all the transvaginal CVS procedures performed for the purpose of prenatal diagnosis in a university-level referral center between January 2000 and December 2014. Women underwent the prenatal testing between 10 and 17 weeks of gestation mainly for hematological disorders involving single gene defects. The main outcomes were successful sampling rate, maternal contamination rate, post-procedure complications rates, and immediate fetal loss rate (<14 days post-procedure).
Results: A total of 1138 transvaginal CVS were performed during the study period and were available for analysis. The sampling success rate after the first attempt was 98.5% (1121/1138) and the overall success rate was 99.6% (1133/1138). The maternal contamination rate was 0.4% (5/1138). While two patients had vaginal bleeding (0.2%), fresh retroplacental collection was noted in four patients (0.4%) post-procedure. None of the patients developed ascending uterine infection following CVS. The immediate fetal loss rate was 0.2% (2/1138).
Conclusion: Transvaginal approach is associated with high sampling success, along with low rates of maternal contamination and post-procedure complications; hence, it can be offered as an effective alternative method of CVS.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/jog.13070 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Trophoblast proliferation is higher in female than in male preeclamptic placentas.
Placenta
December 2024
LMU Munich, Department of Anatomy II, Pettenkoferstr. 11, Munich, 80336, Germany.
Introduction: Preeclampsia (PE) is a pregnancy-specific hypertensive disorder with inflammatory complications. There are no known placental histopathological features, which are unique to PE. It is often pooled with the fetal growth restriction (FGR) under a single umbrella pathophysiology, the maternal vascular malperfusion (MVM).
View Article and Find Full Text PDFConcurrent High-Grade Serous Carcinoma with Mucinous Differentiation and Ectopic Complete Molar Pregnancy of the Fallopian Tube: A Case Report.
Ann Clin Lab Sci
September 2024
Department of Pathology and Laboratory Medicine, Women & Infants Hospital, Providence, RI, USA
Objective: We report the first documented case of concurrent ectopic complete hydatidiform mole (CHM) and high-grade serous carcinoma (HGSC) of the fallopian tube, associated with unique histologic features and mutations in the HGSC.
Case Report: The patient presented with pelvic pain and vaginal bleeding. Laboratory examination revealed a positive urine pregnancy test and high serum beta-human chorionic gonadotropin (β-hCG).
Influence of maternal hyperglycemia on placental capillary distribution.
Einstein (Sao Paulo)
November 2024
Department of Gynecology and Obstetrics, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista "Júlio de Mesquita Filho, Botucatu, SP, Brazil.
Article Synopsis
- * It compared placental samples from three groups: women without diabetes, those with gestational diabetes, and those with a history of diabetes, analyzing their glycemic control and vessel characteristics.
- * Findings revealed that women with gestational or previous diabetes had altered vessel characteristics, including a reduction in the number and area of vessels, indicating that high blood sugar can impact placental blood supply.
E-cadherin/CD34 double immunostaining in placental diagnosis.
Pol J Pathol
October 2024
Division of Pathology, Cincinnati Children's Hospital, Cincinnati, United States.
Placental foetal vascular malperfusion (FVM) may be responsible for complicated foetal or neonatal condition. By highlighting endothelial fragmentation, the double E-cadherin/CD34 immunostain highlights distal villous endothelial fragmentation of recent FVM not seen on haematoxylin-eosin stained sections. We routinely perform the stain on a grossly unremarkable placental sections of placentas predominantly from pregnancies with mass-forming foetal anomalies and umbilical cord complications.
View Article and Find Full Text PDFCharacterising delayed villous maturation: A narrative literature review.
Placenta
December 2024
Maternal and Fetal Health Research Centre, Division of Developmental Biology and Medicine, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Department of Obstetrics, Manchester University NHS Foundation Trust, Manchester, UK.
Article Synopsis
- The placenta's normal development is really important for a baby to grow healthy during pregnancy, but there's a problem called Delayed Villous Maturation (DVM) that can cause stillbirths.
- DVM happens when small structures in the placenta don't develop properly and are fewer in number, which can be linked to conditions like diabetes in mothers, but sometimes it just happens for no clear reason.
- Doctors can only find out if DVM is present after the baby is born by looking at tissues under a microscope, and this review talks about ways to better recognize DVM so that it can be distinguished from healthy placentas.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!